Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer
Clinical trial NCT02403505 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02403505
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2026-11-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.